We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Viral Vector and Plasmid DNA Market Size, Insights, Key Players, Business Opportunities, Covid-19 Impact And Emerging Trends By 2028




 

The latest update of “Global Viral Vector and Plasmid DNA Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Viral Vector and Plasmid DNA Market.

Overview of the Viral Vector and Plasmid DNA Market:

Viral vectors are generally used as vectors for gene therapy, while plasmid DNA is used as raw material in the production of various viral vectors. The manufacturing of viral vectors and plasmid DNA typically involve the use of panomics and systems biology to determine the cause of disease, followed by the use of concentrated drugs to address disease/illness. Moreover, both viral vectors and plasmid DNA can help reduce the cost of treatment and reduce the repeated administration of medications.

Market Drivers:

Increasing number of patients opting for gene therapy to treat diseases, such as heart disease, cancer, diabetes, cystic fibrosis, AIDS, and hemophilia, is expected to aid in the growth of the global viral vector and plasmid DNA market over the forecast period. For instance, in January 2022, Andelyn Biosciences announced the U.S. FDA's acceptance of its GMP plasmid DNA drug master file (DMF). Andelyn is now on track to speed up gene therapy development. This in turn is expected to drive growth of the global viral vector and plasmid DNA market.

Moreover, increasing prevalence of genetic disorders and infectious diseases, rising demand for viral vector-based vaccines for infectious diseases, and increasing number of clinical studies are expected to augment the growth of the global viral vector and plasmid DNA market during the forecast period.

Market Restraints:

High cost of gene therapies and challenges in viral vector manufacturing are expected to hinder growth of the global viral vector and plasmid DNA market over the forecast period.

Regional Insights:

North America, Europe, and Asia Pacific are expected to witness robust growth in the global viral vector and plasmid DNA market owing to the increasing prevalence of genetic disorders and infectious diseases, increasing demand for viral vector-based vaccines, funding for gene therapy development, increasing number of clinical trials, and frequent approvals/launches of novel products in these regions

For instance, in September 2018. Health Canada approved Novartis’ Kymriah, the first gene therapy product to treat cancer. Moreover, in February 2019, Health Canada approved another gene therapy product called Yescarta for an aggressive kind of non-Hodgkins lymphoma, a type of cancer that begins in your lymphatic system.

Competitive Section:

Major companies involved in the global viral vector and plasmid DNA market are Novasep, CobraBiologics, Merck KgaA, Kaneka Eurogentec, Spark Therapeutics, Lonza and UniQure N.V., FUJIFILM Diosynth Ltd., and Cell and Gene Therapy Catapult, among others.

For instance, in June 2020, Aldevron and Ziopharm Oncology teamed up for the production of plasmid DNA for T cell therapy of solid tumors.

Market Estimation:

The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.

COVID-19 Impact:

The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Viral Vector and Plasmid DNA Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.

Market Competition Assessment:

The Viral Vector and Plasmid DNA Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are

  • CobraBiologics
  • Novasep
  • Spark Therapeutics
  • FUJIFILM Diosynth Ltd.
  • Cell and Gene Therapy Catapult
  • Kaneka Eurogentec
  • Merck KGaA
  • Lonza and UniQure N.V. and others

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Viral Vector and Plasmid DNA Market report on the basis of Types, Applications, and Regions.

By Product Type, the market is primarily segmented into:

  • Plasmid DNA
  • Viral Vector
  • Non-Viral Vector

By Applications, the market is segmented into:

  • Cancer
  • Genetic Disorder
  • Others

The report covers the following Regions:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Africa
  • Middle East

Primary Research Insights:

The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.

The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:

  1. What can be the best investment choices for venturing into new product and service lines?
  2. Which regions might see the demand maturing in certain segments in near future?
  3. Which government regulations might challenge the status of key regional markets?
  4. What are some of the value-grab opportunities in various segments?
  5. What will be the barrier to entry for new players in the market?

Why You Should Buy This Report:

  • The report provides an all-inclusive environment of the analysis for the market
  • In-depth secondary research and primary interviews
  • Impact of various social, political, and economic factors
  • Porter’s Five Forces Analysis
  • Competitive Landscape

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Content

 

1 Report Overview

 

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Viral Vector and Plasmid DNA Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Viral Vector and Plasmid DNA Market
1.6.1 How the Covid-19 is Affecting the Viral Vector and Plasmid DNA Market
1.6.1.1 Viral Vector and Plasmid DNA Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Viral Vector and Plasmid DNA Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

 

2 Global Growth Trends by Regions

 

2.1 Viral Vector and Plasmid DNA Market Perspective (2015-2028)
2.2 Viral Vector and Plasmid DNA Market Growth Trends by Regions
2.2.1 Viral Vector and Plasmid DNA Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Viral Vector and Plasmid DNA Market Historic Market Share by Regions (2015-2021)
2.2.3 Viral Vector and Plasmid DNA Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Viral Vector and Plasmid DNA Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Vector and Plasmid DNA Market Players (Opinion Leaders)

 

3 Competition Landscape by Key Players

 

3.1 Global Top Viral Vector and Plasmid DNA Market Players by Market Size
3.1.1 Global Top Viral Vector and Plasmid DNA Market Players by Revenue (2015-2021)
3.1.2 Global Viral Vector and Plasmid DNA Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vector and Plasmid DNA Market Concentration Ratio
3.2.1 Global Viral Vector and Plasmid DNA Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Market Revenue in 2019
3.3 Viral Vector and Plasmid DNA Market Key Players Head office and Area Served
3.4 Key Players Viral Vector and Plasmid DNA Market Product Solution and Service
3.5 Date of entering into Viral Vector and Plasmid DNA Market
3.6 Mergers & Acquisitions, Expansion Plans

 

4 Breakdown Data by Type (2015-2028)

 

4.1 Global Viral Vector and Plasmid DNA Market Historic Market Size by Type (2015-2021)
4.2 Global Viral Vector and Plasmid DNA Market Forecasted Market Size by Type (2021-2028)

 

5 Viral Vector and Plasmid DNA Market Breakdown Data by Application (2015-2028)

 

5.1 Global Viral Vector and Plasmid DNA Market Size by Application (2015-2021)
5.2 Global Viral Vector and Plasmid DNA Market Forecasted Market Size by Application (2021-2028)

 

6 North America

 

6.1 North America Viral Vector and Plasmid DNA Market Size (2015-2021)
6.2 Viral Vector and Plasmid DNA Market Key Players in North America (2019-2021)
6.3 North America Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
6.4 North America Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

7 Europe

 

7.1 Europe Viral Vector and Plasmid DNA Market Size (2015-2021)
7.2 Viral Vector and Plasmid DNA Market Key Players in Europe (2019-2021)
7.3 Europe Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
7.4 Europe Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

8 China

 

8.1 China Viral Vector and Plasmid DNA Market Size (2015-2021)
8.2 Viral Vector and Plasmid DNA Market Key Players in China (2019-2021)
8.3 China Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
8.4 China Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

9 Japan

 

9.1 Japan Viral Vector and Plasmid DNA Market Size (2015-2021)
9.2 Viral Vector and Plasmid DNA Market Key Players in Japan (2019-2021)
9.3 Japan Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
9.4 Japan Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

10 Southeast Asia

 

10.1 Southeast Asia Viral Vector and Plasmid DNA Market Size (2015-2021)
10.2 Viral Vector and Plasmid DNA Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
10.4 Southeast Asia Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

11 India

 

11.1 India Viral Vector and Plasmid DNA Market Size (2015-2021)
11.2 Viral Vector and Plasmid DNA Market Key Players in India (2019-2021)
11.3 India Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
11.4 India Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

12 Central & South America

 

12.1 Central & South America Viral Vector and Plasmid DNA Market Size (2015-2021)
12.2 Viral Vector and Plasmid DNA Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Viral Vector and Plasmid DNA Market Size by Type (2015-2021)
12.4 Central & South America Viral Vector and Plasmid DNA Market Size by Application (2015-2021)

 

13 Key Players Profiles

 

13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Viral Vector and Plasmid DNA Market Introduction
13.4 Viral Vector and Plasmid DNA Market Business (2015-2021)
13.5 Recent Development

 

14 Analyst's Viewpoints/Conclusions

 

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

 

List of Table

 

Table 1. Viral Vector and Plasmid DNA Market Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vector and Plasmid DNA Market Revenue
Table 3. Ranking of Global Top Viral Vector and Plasmid DNA Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Viral Vector and Plasmid DNA Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Viral Vector and Plasmid DNA Market Players to Combat Covid-19 Impact
Table 10. Global Viral Vector and Plasmid DNA Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Viral Vector and Plasmid DNA Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Viral Vector and Plasmid DNA Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Viral Vector and Plasmid DNA Market Share by Regions (2015-2021)
Table 14. Global Viral Vector and Plasmid DNA Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Viral Vector and Plasmid DNA Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Viral Vector and Plasmid DNA Market Growth Strategy
Table 20. Main Points Interviewed from Key Viral Vector and Plasmid DNA Market Players
Table 21. Global Viral Vector and Plasmid DNA Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Viral Vector and Plasmid DNA Market Share by Players (2015-2021)
Table 23. Global Top Viral Vector and Plasmid DNA Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector and Plasmid DNA Market as of 2019)
Table 24. Global Viral Vector and Plasmid DNA Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Viral Vector and Plasmid DNA Market Product Solution and Service
Table 27. Date of entering into Viral Vector and Plasmid DNA Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 30. Global Viral Vector and Plasmid DNA Market Size Share by Type (2015-2021)
Table 31. Global Viral Vector and Plasmid DNA Market Revenue Market Share by Type (2021-2028)
Table 31. Global Viral Vector and Plasmid DNA Market Size Share by Application (2015-2021)
Table 33. Global Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 34. Global Viral Vector and Plasmid DNA Market Size Share by Application (2021-2028)
Table 35. North America Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 37. North America Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 38. North America Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 39. North America Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 40. North America Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 41. Europe Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 43. Europe Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 45. Europe Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 47. China Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 49. China Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 50. China Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 51. China Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 52. China Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 53. Japan Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 55. Japan Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 57. Japan Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 61. Southeast Asia Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 63. Southeast Asia Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 65. India Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 67. India Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 68. India Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 69. India Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 70. India Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Viral Vector and Plasmid DNA Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Viral Vector and Plasmid DNA Market Share (2019-2021)
Table 73. Central & South America Viral Vector and Plasmid DNA Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Viral Vector and Plasmid DNA Market Share by Type (2015-2021)
Table 75. Central & South America Viral Vector and Plasmid DNA Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Viral Vector and Plasmid DNA Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Viral Vector and Plasmid DNA Market Business (2015-2021) (Million US$)
Table 81. Recent Development

 

List of Figures

 

Figure 1. Global Viral Vector and Plasmid DNA Market Share by Type: 2021 VS 2028
Figure 2. Global Viral Vector and Plasmid DNA Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Viral Vector and Plasmid DNA Market Report Years Considered
Figure 8. Global Viral Vector and Plasmid DNA Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Viral Vector and Plasmid DNA Market Share by Regions: 2021 VS 2028
Figure 10. Global Viral Vector and Plasmid DNA Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Viral Vector and Plasmid DNA Market Share by Players in 2019
Figure 13. Global Top Viral Vector and Plasmid DNA Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Viral Vector and Plasmid DNA Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Viral Vector and Plasmid DNA Market Revenue in 2019
Figure 15. North America Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Viral Vector and Plasmid DNA Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.